ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -45.0% | 14,932 | 0.0% | 0.00% | – |
| Q4 2021 | $20,000 | -85.8% | 14,932 | -75.6% | 0.00% | -100.0% |
| Q3 2021 | $141,000 | -31.6% | 61,114 | +30.4% | 0.00% | -42.9% |
| Q2 2021 | $206,000 | -46.5% | 46,874 | -11.7% | 0.01% | -50.0% |
| Q1 2021 | $385,000 | +237.7% | 53,077 | +100.6% | 0.01% | +250.0% |
| Q4 2020 | $114,000 | -81.1% | 26,455 | -47.9% | 0.00% | -92.7% |
| Q3 2019 | $604,000 | – | 50,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |